Publicaties

2014


1. Ghotra VPS, He S, van der Horst G, Nijhoff S, de Bont H, Lekkerkerker A, Janssen R, Jenster G, van Leenders GJHL, Hoogland AM, Baranski Z, van de Water B, van der Pluijm G, Snaar-Jagalska BE, HJ Danen EHJ. In vivo RNAi screen identifies the spleen tyrosine kinase, SYK as a candidate drug target for prostate cancer. Cancer Res 2014 (in press).

2. Zoni E, van der Pluijm G, Gray PC, Kruithof-de Julio M. Epithelial Plasticity in Cancer: unmasking a microRNA network for TGF-β-, Notch- and Wnt-mediated EMT. J. Oncol 2014 (in press).

3. Kroon J, in ’t Veld LS, Buijs JT, Cheung H, van der Horst G, van der Pluijm G. Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth. Oncotarget. 2014 Oct 15;5(19):8986-94.

4. van der Horst G, Bos L, van der Mark M, Cheung H, Heckmann B, Clément-Lacroix P, Lorenzon G, Pelger RC, Bevers RF, van der Pluijm G. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma. PLoS One. 2014 Sep 23;9(9):e108464.       

5. Wissing MD, De Morrée ES, Dezentjé VO, Buijs JT, De Krijger RR, Smit VT, Van Weerden WM, Gelderblom H, van der Pluijm G. Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness. Oncotarget. 2014 Sep 15;5(17):7357-67. 

6. Özdemir BC, Janine Hensel J, Secondini C, Wetterwald A, Schwaninger R,, Fleischmann A, Raffelsberger W, Poch O, Delorenzi M, Temanni R, Mills IG, van der Pluijm G, Thalmann GN, Cecchini MG. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches. PlosOne (in press). 

7. Reeves KJ, Hurrell JE, Cecchini M, van der Pluijm G, Down JM, Eaton CL, Hamdy  F, Clement-Lacroix P, Brown NJ. Prostate cancer cells home to bone using a novel in vivo model: Modulation by the integrin antagonist GLPG0187. Int J Cancer. 2014 Aug 23. 

8. Bachelier R, Confavreux CB, Peyruchaud O, Croset M, Goehrig D, van der Pluijm G, Clézardin P. Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis. Int J Cancer. 2014 Sep 15;135(6):1319-29. 

9. Riplinger SM, Wabnitz GH, Kirchgessner H, Jahraus B, Lasitschka F, Schulte B, van der Pluijm G, van der Horst G, Hämmerling GJ, Nakchbandi I, Samstag Y. Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation. Mol Cancer. 2014 Jan 18;13:10. 

10. Kroon J, Metselaar JM, Storm G, van der Pluijm G. Liposomal nanomedicines in the treatment of prostate cancer. Cancer Treat Rev. 2014 May;40(4):578-84.   

11. Wissing MD, van Leeuwen FW, van der Pluijm G, Gelderblom H. Radium-223chloride: Extending life in prostate cancer patients by treating bone metastases.  Clin Cancer Res. 2013 Nov 1;19(21):5822-7.

12. Nicolai MP, Liem SS, Both S, Pelger RC, Putter H, Schalij MJ, Elzevier HW. A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice. Neth Heart J. 2014 Jan;22(1):11-9.

13. Nicolai MP, van Bavel J, Somsen GA, de Grooth GJ, Tulevski II, Lorsheyd A, Putter H, Schalij MJ, Pelger RC, Elzevier HW. Erectile dysfunction in the cardiology practice-a patients' perspective. Am Heart J. 2014 Feb;167(2):178-85.

14. Nicolai MP, Keller JJ, de Vries L, van der Meulen-de Jong AE, Nicolai JJ, Hardwick JC, Putter H, Pelger RC, Elzevier HW. The impact of sexual abuse in patients undergoing colonoscopy. PLoS One. 2014 Jan 15;9(1):e85034.

15. Nicolai MP, Elzevier HW. Do residents in cardiology need more training to make them talk about sex? Neth Heart J. 2014 Mar;22(3):122-3.

16. Schaafsma BE, Verbeek FP, Elzevier HW, Tummers QR, van der Vorst JR, Frangioni JV, van de Velde CJ, Pelger RC, Vahrmeijer AL. Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging. J Surg Oncol. 2014 Dec;110(7):845-50. 3.

17. Hogewoning CR, Gietelink L, Pelger RC, Hogewoning CJ, Bekker MD, Elzevier HW. The introduction of mid-urethral slings: an evaluation of literature. Int Urogynecol J. 2014 In press